Desipramine Activated Bcl-2 Expression and Inhibited Lipopolysaccharide-Induced Apoptosis in Hippocampus-Derived Adult Neural Stem Cells
-
- Huang Yu-Yin
- Department of Anesthesiology, Taipei Veterans General Hospital and National Yang-Ming University, Taiwan Department of Anesthesiology, Cheng-Hsin Rehabilitation Medical Center, Taiwan Institute of Clinical Medicine, National Yang-Ming University, Taiwan
-
- Peng Chi-Hsien
- Department of Ophthalmology, Taipei Veterans General Hospital and National Yang-Ming University, Taiwan Institute of Clinical Medicine, National Yang-Ming University, Taiwan Shin Kong Wu Ho-Su Memorial Hospital, Taiwan
-
- Yang Yi-Ping
- Department of Pharmacy, Taipei Veterans General Hospital and National Yang-Ming University, Taiwan
-
- Wu Chih-Chiau
- Department of Ophthalmology, Taipei Veterans General Hospital and National Yang-Ming University, Taiwan
-
- Hsu Wen-Ming
- Department of Ophthalmology, Taipei Veterans General Hospital and National Yang-Ming University, Taiwan
-
- Wang Hsiao-Jung
- Department of Pharmacy, Taipei Veterans General Hospital and National Yang-Ming University, Taiwan
-
- Chan Kwok-Han
- Department of Anesthesiology, Taipei Veterans General Hospital and National Yang-Ming University, Taiwan
-
- Chou Yi-Pen
- Department of Anesthesiology, Cheng-Hsin Rehabilitation Medical Center, Taiwan
-
- Chen Shih-Jen
- Department of Ophthalmology, Taipei Veterans General Hospital and National Yang-Ming University, Taiwan
-
- Chang Yuh-Lih
- Department of Pharmacy, Taipei Veterans General Hospital and National Yang-Ming University, Taiwan Department of Pharmacy, Chia Nan University of Pharmacy and Science, Taiwan
この論文をさがす
抄録
Desipramine (DP) is a tricyclic antidepressant used for treating depression and numerous other psychiatric disorders. Recent studies have shown that DP can promote neurogenesis and improve the survival rate of hippocampal neurons. However, whether DP induces neuroprotection or promotes the differentiation of neural stem cells (NSCs) needs to be elucidated. In this study, we cultured NSCs derived from the hippocampal tissues of adult rats as an in vitro model to evaluate the modulation effect of DP on NSCs. First, we demonstrated that the expression of Bcl-2 mRNA and nestin in 2 μM DP-treated NSCs were up-regulated and detected by real-time reverse transcriptase polymerase chain reaction (RT-PCR). The results of Western blotting and immunofluorescent study confirmed that Bcl-2 protein expression was significantly increased in Day 3 DP-treated NSCs. Using the Bcl-2 small interfering RNA (siRNA) method, our results further showed that DP protects the lipopolysaccharide (LPS)-induced apoptosis in NSCs, in part by activating the expression of Bcl-2. Furthermore, DP treatment significantly inhibited the induction of proinflammatory factor interleukin (IL)-1β, IL-6, and tumor necrosis factor-α in the culture medium of LPS-treated NSCs mediated by Bcl-2 modulation. The results of high performance liquid chromatography coupled to electrochemical detection further confirmed that DP significantly increased the functional production of serotonin (26 ± 3.5 μM, DP-treated 96 h) and noradrenaline (50 ± 8.9 μM, DP-treated 96 h) in NSCs through activation of the MAPK/ERK pathway and partially mediated by Bcl-2. In conclusion, the present results indicate that DP can increase neuroprotection ability by inhibiting the LPS-induced inflammatory process in NSCs via the modulation of Bcl-2 expression, as confirmed by the siRNA method.<br>
収録刊行物
-
- Journal of Pharmacological Sciences
-
Journal of Pharmacological Sciences 104 (1), 61-72, 2007
公益社団法人 日本薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282680152260736
-
- NII論文ID
- 10024314003
-
- NII書誌ID
- AA11806667
-
- ISSN
- 13478648
- 13478613
-
- NDL書誌ID
- 8737742
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可